Startup expansions show how UChicago researchers are bringing their work to society
Three ‘exits’ in a row by UChicago startup companies demonstrate broadening reach
Next-generation cancer drugs boost immunotherapy responses
<p>Prof. Thomas Gajewski assesses prospects for new cancer therapies</p>
Nature
The Hottest New Cancer Drugs Depend on Gut Microbes
<p>Prof. Thomas Gajewski leads study, which finds gut microbiome composition can affect the body’s immune response to cancer</p>
